Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Erratum for Mor et al., "Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids".

Mor V, Rella A, Farnoud AM, Singh A, Munshi M, Bryan A, Naseem S, Konopka JB, Ojima I, Bullesbach E, Ashbaugh A, Linke MJ, Cushion M, Collins M, Ananthula HK, Sallans L, Desai PB, Wiederhold NP, Fothergill AW, Kirkpatrick WR, Patterson T, Wong LH, Sinha S, Giaever G, Nislow C, Flaherty P, Pan X, Cesar GV, de Melo Tavares P, Frases S, Miranda K, Rodrigues ML, Luberto C, Nimrichter L, Del Poeta M.

MBio. 2018 Mar 13;9(2). pii: e00188-18. doi: 10.1128/mBio.00188-18. No abstract available.

2.

Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids.

Lazzarini C, Haranahalli K, Rieger R, Ananthula HK, Desai PB, Ashbaugh A, Linke MJ, Cushion MT, Ruzsicska B, Haley J, Ojima I, Del Poeta M.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00156-18. doi: 10.1128/AAC.00156-18. Print 2018 May.

3.

Gene Expression of Pneumocystis murina after Treatment with Anidulafungin Results in Strong Signals for Sexual Reproduction, Cell Wall Integrity, and Cell Cycle Arrest, Indicating a Requirement for Ascus Formation for Proliferation.

Cushion MT, Ashbaugh A, Hendrix K, Linke MJ, Tisdale N, Sayson SG, Porollo A.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02513-17. doi: 10.1128/AAC.02513-17. Print 2018 May.

4.

Author response.

Espay AJ, Dwivedi A, Lang AE, Linke MJ, Szaflarski JP.

Neurology. 2015 Aug 25;85(8):742-3. doi: 10.1212/WNL.0000000000001879. No abstract available.

PMID:
26304681
5.

Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids.

Mor V, Rella A, Farnoud AM, Singh A, Munshi M, Bryan A, Naseem S, Konopka JB, Ojima I, Bullesbach E, Ashbaugh A, Linke MJ, Cushion M, Collins M, Ananthula HK, Sallans L, Desai PB, Wiederhold NP, Fothergill AW, Kirkpatrick WR, Patterson T, Wong LH, Sinha S, Giaever G, Nislow C, Flaherty P, Pan X, Cesar GV, de Melo Tavares P, Frases S, Miranda K, Rodrigues ML, Luberto C, Nimrichter L, Del Poeta M.

MBio. 2015 Jun 23;6(3):e00647. doi: 10.1128/mBio.00647-15. Erratum in: MBio. 2018 Mar 13;9(2):.

6.

Placebo effect of medication cost in Parkinson disease: a randomized double-blind study.

Espay AJ, Norris MM, Eliassen JC, Dwivedi A, Smith MS, Banks C, Allendorfer JB, Lang AE, Fleck DE, Linke MJ, Szaflarski JP.

Neurology. 2015 Feb 24;84(8):794-802. doi: 10.1212/WNL.0000000000001282. Epub 2015 Jan 28.

7.

Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.

Linke MJ, Ashbaugh A, Collins MS, Lynch K, Cushion MT.

Infect Immun. 2013 Mar;81(3):984-95. doi: 10.1128/IAI.01181-12. Epub 2013 Jan 14.

8.

Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection.

Cushion MT, Linke MJ, Ashbaugh A, Sesterhenn T, Collins MS, Lynch K, Brubaker R, Walzer PD.

PLoS One. 2010 Jan 29;5(1):e8524. doi: 10.1371/journal.pone.0008524.

9.

Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice.

Linke MJ, Ashbaugh AA, Koch JV, Levin L, Tanaka R, Walzer PD.

J Eukaryot Microbiol. 2009 Jan-Feb;56(1):58-65. doi: 10.1111/j.1550-7408.2008.00363.x.

10.

Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.

Linke MJ, Ashbaugh AD, Demland JA, Walzer PD.

Respir Res. 2009 Feb 19;10:10. doi: 10.1186/1465-9921-10-10.

11.

Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema.

Motz GT, Eppert BL, Sun G, Wesselkamper SC, Linke MJ, Deka R, Borchers MT.

J Immunol. 2008 Dec 1;181(11):8036-43.

12.

Biofilm formation by Pneumocystis spp.

Cushion MT, Collins MS, Linke MJ.

Eukaryot Cell. 2009 Feb;8(2):197-206. doi: 10.1128/EC.00202-08. Epub 2008 Sep 26.

14.

Pneumocystis murina MSG gene family and the structure of the locus associated with its transcription.

Keely SP, Linke MJ, Cushion MT, Stringer JR.

Fungal Genet Biol. 2007 Sep;44(9):905-19. Epub 2007 Jan 10.

15.
16.

Delayed profound local brain hypothermia markedly reduces interleukin-1beta gene expression and vasogenic edema development in a porcine model of intracerebral hemorrhage.

Wagner KR, Beiler S, Beiler C, Kirkman J, Casey K, Robinson T, Larnard D, de Courten-Myers GM, Linke MJ, Zuccarello M.

Acta Neurochir Suppl. 2006;96:177-82.

PMID:
16671450
17.
18.
19.

Noninvasive method for monitoring Pneumocystis carinii pneumonia.

Linke MJ, Rebholz S, Collins M, Tanaka R, Cushion MT.

Emerg Infect Dis. 2003 Dec;9(12):1613-6.

20.

New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies.

Thullen TD, Ashbaugh AD, Daly KR, Linke MJ, Steele PE, Walzer PD.

Infect Immun. 2003 Nov;71(11):6292-7.

21.

Protein oxidation and heme oxygenase-1 induction in porcine white matter following intracerebral infusions of whole blood or plasma.

Wagner KR, Packard BA, Hall CL, Smulian AG, Linke MJ, De Courten-Myers GM, Packard LM, Hall NC.

Dev Neurosci. 2002;24(2-3):154-60.

PMID:
12401953
22.

Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.

Daly KR, Fichtenbaum CJ, Tanaka R, Linke MJ, O'Bert R, Thullen TD, Hui MS, Smulian AG, Walzer PD.

J Infect Dis. 2002 Sep 1;186(5):644-51. Epub 2002 Aug 9.

PMID:
12195351
23.

Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.

Linke MJ, Harris CE, Korfhagen TR, McCormack FX, Ashbaugh AD, Steele P, Whitsett JA, Walzer PD.

J Infect Dis. 2001 Mar 15;183(6):943-52. Epub 2001 Feb 15.

PMID:
11237812
24.

The minimum number of Pneumocystis carinii f. sp. carinii organisms required to establish infections is very low.

Cushion MT, Linke MJ, Collins M, Keely SP, Stringer JR.

J Eukaryot Microbiol. 1999 Sep-Oct;46(5):111S. No abstract available.

PMID:
10519272
25.

Latent Pneumocystis carinii infection in commercial rat colonies: comparison of inductive immunosuppressants plus histopathology, PCR, and serology as detection methods.

Weisbroth SH, Geistfeld J, Weisbroth SP, Williams B, Feldman SH, Linke MJ, Orr S, Cushion MT.

J Clin Microbiol. 1999 May;37(5):1441-6.

26.

Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response.

Theus SA, Smulian AG, Steele P, Linke MJ, Walzer PD.

Vaccine. 1998 Jul;16(11-12):1149-57.

PMID:
9682373
27.

Expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp. carinii.

Linke MJ, Sunkin SM, Andrews RP, Stringer JR, Walzer PD.

Clin Diagn Lab Immunol. 1998 Jan;5(1):50-7.

28.

Identification of a putative precursor to the major surface glycoprotein of Pneumocystis carinii.

Sunkin SM, Linke MJ, McCormack FX, Walzer PD, Stringer JR.

Infect Immun. 1998 Feb;66(2):741-6.

29.

Terminology for the life cycle of Pneumocystis carinii.

Cushion MT, Walzer PD, Smulian AG, Linke MJ, Ruffolo JJ, Kaneshiro ES, Stringer JR.

Infect Immun. 1997 Oct;65(10):4365; author reply 4366. No abstract available.

30.

Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii.

Theus SA, Andrews RP, Linke MJ, Walzer PD.

J Eukaryot Microbiol. 1997 Mar-Apr;44(2):96-100.

PMID:
9109259
31.

Surfactant phospholipid secretion from rat alveolar type II cells: possible role of PKC isozymes.

Linke MJ, Burton FM, Fiedeldey DT, Rice WR.

Am J Physiol. 1997 Feb;272(2 Pt 1):L171-7.

PMID:
9124366
32.

Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs.

Walzer PD, Runck J, Steele P, White M, Linke MJ, Sidman CL.

Antimicrob Agents Chemother. 1997 Feb;41(2):251-8.

33.

Antigenic differences associated with genetically distinct Pneumocystis carinii from rats.

Vasquez J, Smulian AG, Linke MJ, Cushion MT.

Infect Immun. 1996 Jan;64(1):290-7.

34.

Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis.

Keely SP, Stringer JR, Baughman RP, Linke MJ, Walzer PD, Smulian AG.

J Infect Dis. 1995 Aug;172(2):595-8.

PMID:
7542688
35.

Analysis of Pneumocystis carinii organism burden, viability and antigens in bronchoalveolar lavage fluid in AIDS patients with pneumocystosis: correlation with disease severity.

Smulian AG, Linke MJ, Cushion MT, Baughman RP, Frame PT, Dohn MN, White ML, Walzer PD.

AIDS. 1994 Nov;8(11):1555-62.

PMID:
7531457
36.

Production and characterization of monoclonal antibodies specific for the major surface glycoprotein of Pneumocystis carinii.

Linke MJ, Smulian AG, Yoshihara P, Walzer PD.

J Eukaryot Microbiol. 1994 Sep-Oct;41(5):99S-100S. No abstract available.

PMID:
7804293
37.

Antigenic differences among genetically distinct types of rat-derived Pneumocystis carinii.

Vasquez J, Smulian AG, Linke MJ, Cushion MT.

J Eukaryot Microbiol. 1994 Sep-Oct;41(5):114S. No abstract available.

PMID:
7804207
38.

A survey of birds in Denmark for the presence of Pneumocystis carinii.

Settnes OP, Nielsen PB, Bucala R, Linke MJ, Cushion MT.

Avian Dis. 1994 Jan-Mar;38(1):1-10.

PMID:
8002876
39.

Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derived Pneumocystis carinii.

Linke MJ, Smulian AG, Stringer JR, Walzer PD.

Parasitol Res. 1994;80(6):478-86.

PMID:
7808998
40.
41.

Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii.

Theus SA, Linke MJ, Andrews RP, Walzer PD.

Infect Immun. 1993 Nov;61(11):4703-9.

42.

Geographic variation in the humoral response to Pneumocystis carinii.

Smulian AG, Sullivan DW, Linke MJ, Halsey NA, Quinn TC, MacPhail AP, Hernandez-Avila MA, Hong ST, Walzer PD.

J Infect Dis. 1993 May;167(5):1243-7.

PMID:
8486964
43.

Isolation and characterization of a recombinant antigen of Pneumocystis carinii.

Smulian AG, Stringer JR, Linke MJ, Walzer PD.

Infect Immun. 1992 Mar;60(3):907-15.

44.

Expression cloning of Pneumocystis carinii antigens.

Smulian AG, Stringer JR, Linke MJ, Walzer PD.

J Protozool. 1991 Nov-Dec;38(6):8S-10S.

PMID:
1818218
45.
46.

Factors influencing Pneumocystis infection in the immunocompromised rat.

Cushion MT, Linke MJ.

J Protozool. 1991 Nov-Dec;38(6):133S-135S. Erratum in: J Protozool 1992 May-Jun;39(3):398.

PMID:
1818138
47.

Serologic responses to Pneumocystis carinii antigens in health and disease.

Peglow SL, Smulian AG, Linke MJ, Pogue CL, Nurre S, Crisler J, Phair J, Gold JW, Armstrong D, Walzer PD.

J Infect Dis. 1990 Feb;161(2):296-306.

PMID:
2299209
48.

Identity of a cytosolic neutral cholesterol esterase in rat liver with the bile salt stimulated cholesterol esterase in pancreas.

Camulli ED, Linke MJ, Brockman HL, Hui DY.

Biochim Biophys Acta. 1989 Sep 25;1005(2):177-82.

PMID:
2775770
49.

Properties of the major antigens of rat and human Pneumocystis carinii.

Linke MJ, Cushion MT, Walzer PD.

Infect Immun. 1989 May;57(5):1547-55.

50.

Analysis of a surface antigen of Pneumocystis carinii.

Linke MJ, Walzer PD.

J Protozool. 1989 Jan-Feb;36(1):60S-61S.

PMID:
2785200

Supplemental Content

Loading ...
Support Center